The Study of Mechanism of Chronic Insomnia Disorder Using Acupuncture

Status Recruiting

Clinical Trial Summary

Insomnia disorder is one of the major neuropsychiatric diseases which received more attention in recent years. Disturbances in the amino acid neurotransmitter, gama-amino butyric acid (GABA) and hyperarousal of cortex are hypothesized to contribute to the neurobiology of insomnia. Both animal experiment and clinical observation have demonstrated that acupuncture can generate treatment effect on insomnia symptom. However, the underlying mechanism remains unclear. The principal objective of this project is to use magnetic resonance spectroscopy (MRS) as well as acupuncture to provide the first in vivo characterization of cortical GABA levels between pro- and post-acupuncture treatment in individuals with chronic insomnia disorder (CID), and use resting state functional magnetic resonance imaging (fMRI) to determine whether CID patients have altered brain connectivity and network parameter changes. The investigators are also exploring the correlation between cortical GABA levels, fMRI parameter changes and abnormalities in sleep parameters and neuropsychology test in CID patients.

Clinical Trial Description

Three groups of subjects (CID accepted true acupuncture, CID accepted sham acupuncture and healthy) will participate in the study. All subjects will undergo a laboratory blood test, physical and neurological examination, polysomnography (PSG) and an extensive battery of neuropsychological assessments. All subjects meeting eligibility criteria for the study will complete a baseline MRS and fMRI to evaluate differences in multi-modality brain GABA and fMRI parameters between the patients and healthy. After randomized acupuncture treatment, investigators will compare brain metabolic and functional parameters to elucidate the neural mechanism of acupuncture therapy on insomnia, provide theoretical evidence from the perspective of neurotransmitters and brain network. ;

Study Design

Related Conditions & MeSH terms

Insomnia Disorder
Sleep Initiation and Maintenance Disorders

Clinical Trial Details

NCT number	NCT03237338
Study type	Interventional
Source	Dongfang Hospital Beijing University of Chinese Medicine
Contact	Ran Pang, doctor
Phone	861067693481
Email	pangrandf@163.com
Status	Recruiting
Phase	N/A
Start date	December 26, 2017
Completion date	December 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00821041` - Internet-based Treatment for Chronic Insomnia	Phase 2
Completed	`NCT03727438` - Provider Supported Self-Help Cognitive Behavioral Therapy for Insomnia (Tele-Self CBTI)	N/A
Recruiting	`NCT03633305` - Optimization of Insomnia Treatment in Primary Care	N/A
Completed	`NCT04616157` - Internet-based Cognitive Behavioral Therapy for Adolescents With Sleep Problems- a Feasibility Trial	N/A
Completed	`NCT03679884` - Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep	Phase 3
Completed	`NCT02839200` - Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder	Phase 2
Recruiting	`NCT04752254` - Investigating Racing Thoughts in Patients With Insomnia Disorder
Completed	`NCT05558865` - Effectiveness of a Digital Health Application for People With Insomnia Disorder (Somnovia)	N/A
Completed	`NCT05541055` - Digital CBT-I for Insomnia Disorder	N/A
Active, not recruiting	`NCT06393504` - Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)
Completed	`NCT02841709` - Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder	Phase 2
Completed	`NCT03328585` - Telemedicine vs. In-person Delivery of Cognitive Behavioral Treatment of Insomnia: a Mixed Methods Analysis	N/A
Completed	`NCT02952820` - Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)	Phase 3
Recruiting	`NCT05408078` - Become Your Own SLEEPexpert: a Behavioral Treatment Program for Insomnia in Patients With Psychiatric Disorders	N/A
Recruiting	`NCT05780983` - Sleep Well 24 (SWELL24) Healthy Sleep-Wake Behaviors in Older Adults	N/A
Completed	`NCT03575104` - Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep	Phase 3
Not yet recruiting	`NCT06279286` - Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder	Phase 1/Phase 2
Terminated	`NCT02571595` - A Sleep Program to Improve Sleep Quality in People With HIV	N/A
Completed	`NCT00984698` - A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)	N/A
Recruiting	`NCT05780177` - Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Study of Mechanism of Chronic Insomnia Disorder Using Acupuncture Based on Changes of Brain GABA and fMRI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms